HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease
Free-Photos / Pixabay

HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease

According to a story from PR Newswire, the Hereditary Neuropathy Foundation (HNF) recently announced that it will be conducting a meeting with the US Food and Drug Administration (FDA). This…

Continue Reading HNF to Meet With The FDA to Discuss Treatments for Charcot-Marie-Tooth Disease
A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
paulbr75 / Pixabay

A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink

According to a story from The Chicago Tribune, Darnesha Bankston, age 23, was rushed to the hospital just before Christmas last year with a bunch of severe, life threatening symptoms.…

Continue Reading A Woman With Atypical Hemolytic Uremic Syndrome Was Brought Back From The Brink
Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year
mwooten / Pixabay

Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year

According to a story from Euroinvestor, the biotechnology company argenx recently announced that it has gotten correspondence from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) in regards to the design…

Continue Reading Global Phase 3 Trial For Experimental Myasthenia Gravis Treatment to Begin Before The End of The Year

ICYMI: Study Suggests That PARP Inhibitors Could be a Effective for BRCA Mutated Breast Cancer

According to a story from Oncology Times, a recent study indicates that the PARP inhibitor drug talazoparib could be an effective treatment option for patients with advanced, HER-2 negative, BRCA…

Continue Reading ICYMI: Study Suggests That PARP Inhibitors Could be a Effective for BRCA Mutated Breast Cancer
Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome
lisichik / Pixabay

Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome

According to a story from the Santa Cruz Sentinel, the earliest results from a critical gene editing study could offer some encouragement for those hoping to treat rare genetic diseases…

Continue Reading Preliminary Results of Gene Editing Experiment Suggest Potential for Treating Hunter Syndrome
Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved
DarkoStojanovic / Pixabay

Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved

The biotechnology company Synlogic announced positive data from its most recent Phase 1/2a clinical trial of its experimental product SYNB1618. This trial did not test the therapeutic action of the…

Continue Reading Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved

Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer

According to a story from medicinenet.com, a recent study found that women on Medicare are not getting genetic tests for BRCA mutations that could lead to ovarian cancer and breast…

Continue Reading Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer
Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests
qimono / Pixabay

Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests

According to a story from Multiple Sclerosis News Today, a recent case report suggests that switching from the immunotherapy drug Gilenya to another immunotherapy called Lemtrada could cause a severe…

Continue Reading Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests
Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation
Hans / Pixabay

Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the gene therapy company Reflection Biotechnologies Ltd. recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to its…

Continue Reading Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging